Philipp Haas holds an MBA in banking from St. Gallen University of Economics, Law, and Business Administration. He is fluent in German, English, French, Spanish, Portuguese, Italian, and Turkish. Since 1992, he has held various positions in investment consultancy and management. He has extensive experience in Eastern European and particularly Turkish markets. He has participated in numerous restructuring projects in Ukraine and Türkiye. In the 1990s, he served on the boards of Rogan Brewery in Ukraine and Net Holding in Türkiye on behalf of institutional foreign investors. He has extensive experience in the pharmaceutical industry, having consulted for Slovakopharma (later Zentiva) to direct Eastern European investments. He chairs the boards of EastPharma Ltd and DEVA Holding. He also chairs the boards of Saba İlaç Sanayi ve Ticaret A.Ş., New Life Yaşam Sigorta A.Ş., and Eastpharma İlaç Üretim Pazarlama San. ve Tic. A.Ş., and serves as a Board Member at Eastpharma Sarl. Within the group, he serves as manager at Devatis Ltd, Devatis GmbH, Devatis AG, Devatis de Mexico S.DE RL. DE C.V, Devatis Pty Ltd, Devatis Canada Inc., Devatis d.o.o. Beograde, Devatis B.V., Devatis LLC, and as Board Member and CEO at Devatis Inc.